CN1191493A - 体内糖尿病检测 - Google Patents

体内糖尿病检测 Download PDF

Info

Publication number
CN1191493A
CN1191493A CN96195689A CN96195689A CN1191493A CN 1191493 A CN1191493 A CN 1191493A CN 96195689 A CN96195689 A CN 96195689A CN 96195689 A CN96195689 A CN 96195689A CN 1191493 A CN1191493 A CN 1191493A
Authority
CN
China
Prior art keywords
peptide
application
autoreactivity
cell
aminoacid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN96195689A
Other languages
English (en)
Chinese (zh)
Inventor
J·安德尔
M·甘兹
P·斯塔尔
R·基恩施恩盖尔
G·G·朱恩格
P·波兹里
F·多尼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of CN1191493A publication Critical patent/CN1191493A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0006—Skin tests, e.g. intradermal testing, test strips, delayed hypersensitivity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rehabilitation Therapy (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
CN96195689A 1995-07-20 1996-07-19 体内糖尿病检测 Pending CN1191493A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19526561.0 1995-07-20
DE19526561A DE19526561A1 (de) 1995-07-20 1995-07-20 In-vivo-Diabetes-Test

Publications (1)

Publication Number Publication Date
CN1191493A true CN1191493A (zh) 1998-08-26

Family

ID=7767366

Family Applications (1)

Application Number Title Priority Date Filing Date
CN96195689A Pending CN1191493A (zh) 1995-07-20 1996-07-19 体内糖尿病检测

Country Status (10)

Country Link
EP (1) EP0839058A2 (de)
JP (1) JPH11509538A (de)
KR (1) KR19990035757A (de)
CN (1) CN1191493A (de)
AU (1) AU6658296A (de)
CA (1) CA2225145A1 (de)
DE (1) DE19526561A1 (de)
IL (1) IL122816A0 (de)
NO (1) NO980252D0 (de)
WO (1) WO1997003704A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997036618A1 (fr) * 1996-04-01 1997-10-09 Chugai Seiyaku Kabushiki Kaisha Composition diagnostique pour maladies s'accompagnant de reactions auto-immunes declenchees par la decarboxylase d'acide 65k-glutamique
US6750201B1 (en) * 1997-10-17 2004-06-15 The Trustees Of The University Of Pennsylvania Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator
KR100681339B1 (ko) * 2004-12-23 2007-02-15 최성환 연탄보일러

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3626054A (en) * 1967-10-25 1971-12-07 Bard Hamilton Co Inc Lupus erythematosus skin test
US5674978A (en) * 1990-09-21 1997-10-07 The Regents Of The University Of California Peptides derived from glutamic acid decarboxylase
CA2140591A1 (en) * 1994-01-20 1995-07-21 Josef Endl Antigen-specific, activated t lymphocytes, detection and use
DE19525784A1 (de) * 1995-07-14 1997-01-16 Boehringer Mannheim Gmbh Autoreaktive Peptide aus der humanen Glutamin-Decarboxylase (GAD)

Also Published As

Publication number Publication date
IL122816A0 (en) 1998-08-16
AU6658296A (en) 1997-02-18
NO980252L (no) 1998-01-20
DE19526561A1 (de) 1997-01-23
KR19990035757A (ko) 1999-05-25
JPH11509538A (ja) 1999-08-24
WO1997003704A2 (de) 1997-02-06
NO980252D0 (no) 1998-01-20
CA2225145A1 (en) 1997-02-06
EP0839058A2 (de) 1998-05-06
WO1997003704A3 (de) 1997-06-05

Similar Documents

Publication Publication Date Title
Unanue et al. The basis for the immunoregulatory role of macrophages and other accessory cells
US20200407424A1 (en) Novel complexes of types of mhc class ii that bind to collagen type ii peptides and their use on diagnosis and treatment
EP2190473B1 (de) Peptid mit reduzierter dimer-bildung
US8198401B2 (en) Peptides associated with HLA-DR MHC class II molecule and involved in rheumatoid arthritis
US8652488B2 (en) Insulin B chain autoantigen composition
CN101039953B (zh) 治疗和诊断剂
CN1188485A (zh) 胰高血糖素样肽-2及其治疗应用
CN103068842A (zh) 对胰岛素受体具有高活性的单链胰岛素激动剂
JP2019056013A (ja) ヒト成長ホルモン類似体を用いた小児成長ホルモン分泌不全症の治療
CN1112933A (zh) 抗原特异性活化t淋巴细胞，其检测和用途
CN1242802A (zh) Notch蛋白及其配体
JP2017125051A (ja) Ｈｇｈ−ｘｔｅｎ融合タンパク質および成長ホルモン欠乏症の処置におけるその使用
CN86102858A (zh) 制备猪支原体的重组表面抗原及其疫苗的方法
CN1175214A (zh) 肽p277类似物及含有它们的诊断和治疗糖尿病的药物组合物
CN103298482B (zh) 用于免疫耐受性诱导和免疫诊断的fviii肽
WO2003004057A1 (en) Ephrin and eph receptor mediated immune modulation
AU2015302930A1 (en) Methods of treating cervical cancer
RU96115937A (ru) Новые пептиды, являющиеся производными аутоантигена, предназначенные для использования в иммунотерапии аутоиммунных заболеваний
EA017999B1 (ru) Композиция, содержащая пептиды основного белка миелина, ее применение и способ лечения или профилактики рассеянного склероза или оптического неврита
JPH1175868A (ja) 新規化合物
JPH11500719A (ja) インシュリン依存性糖尿病（ｉｄｄｍ）患者に作用する免疫反応および免疫治療分子
CN1191493A (zh) 体内糖尿病检测
JP2004532896A (ja) Ｉ型糖尿病の診断及び治療
JPH09510437A (ja) Ｔ細胞エピトープ
Liu et al. Amino acid sequence of an immunogenic corneal stromal protein.

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication